Terminal
Spotlight
Cashu Research

← Back to Terminal

Stocks
Healthcare
NASDAQ
TLSI

Market Cap: $223.29M

TI

TriSalus Life Sciences, Inc.

TLSI

NASDAQ (NASDAQ Global Market)USD

Overview News Analyst Reports Financials Politician Trades Insider Trades Executive

By Cashu Finance. Providing market news, analysis, and research for investors worldwide.

Company

Stocks About Advertisers Brokers Contact

Legal

Terms of Service Privacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Finance is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Finance is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Finance and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Cashu Research is part of Cashu Technology Pty Ltd, which is an authorised representative (AR # 001318029) of Adviser Solutions Group Pty Ltd (ABN 88 601 875 521) (AFSL 485946) (ASG).

This material is general advice only and is not an offer for the purchase or sale of any financial product or service. The material is not intended to provide you with personal financial or tax advice and does not take into account your personal objectives, financial situation or needs. Although we believe that the material is correct, no warranty of accuracy, reliability or completeness is given, except for liability under statute which cannot be excluded. Please note that past performance may not be indicative of future performance and that no guarantee of performance, the return of capital or a particular rate of return is given by Cashu Technologies Pty Ltd, any of their related body corporates or any other person. To the maximum extent possible, Cashu Technologies Pty Ltd, their related body corporates or any other person do not accept any liability for any statement in this material.

News

TriSalus Life Sciences Appoints New Board Members to Enhance Oncology Innovations

TriSalus Life Sciences Welcomes New Board Members to Propel Oncology Innovations TriSalus Life Sciences® Inc., a pioneering biomedical technology company dedicated to enhancing treatment outcomes for…

Cashu Finance·over 1 year ago

TriSalus Life Sciences Strengthens Leadership with New Board Appointments for Cancer Innovation

TriSalus Life Sciences Strengthens Leadership with Key Appointments TriSalus Life Sciences Inc., a pioneering biomedical technology company focused on enhancing treatment outcomes for solid tumors, an…

Cashu Finance·over 1 year ago

TriSalus Life Sciences Reports 59% Revenue Growth Driven by TriNav® Infusion System

TriSalus Life Sciences Reports Strong Growth Driven by TriNav® Infusion System TriSalus Life Sciences Inc. announces preliminary unaudited financial results for the fourth quarter and full year of 202…

Cashu Finance·almost 2 years ago

TriSalus Life Sciences Reports 44% Q4 Revenue Growth Driven by TriNav® Infusion System

TriSalus Life Sciences Shows Robust Growth with TriNav® Infusion System TriSalus Life Sciences® Inc. reveals impressive preliminary financial results for the fourth quarter and full year of 2024, larg…

Cashu Finance·almost 2 years ago

TriSalus Life Sciences Partners with Geo-Med to Improve Liver Cancer Treatment for Veterans

TriSalus Life Sciences Partners with Geo-Med to Enhance Liver Cancer Treatment for Veterans TriSalus Life Sciences Inc. has entered a strategic partnership with Geo-Med, LLC, a certified Service-Disab…

Cashu Finance·almost 2 years ago

TriSalus Life Sciences Partners with Geo-Med to Improve Liver Cancer Treatment for Veterans

TriSalus Life Sciences Partners with Geo-Med to Enhance Treatment for Veterans with Liver Cancer TriSalus Life Sciences Inc. (Nasdaq: TLSI), an innovative oncology company, announces a strategic partn…

Cashu Finance·almost 2 years ago

TriSalus Life Sciences Innovates Drug Delivery for Liver and Pancreatic Cancer Treatments

TriSalus Life Sciences Advances Drug Delivery for Challenging Cancers TriSalus Life Sciences Inc., a prominent player in the oncology-focused medical technology sector, is making significant strides i…

Cashu Finance·almost 2 years ago

TriSalus Life Sciences Innovates Drug Delivery for Liver and Pancreatic Cancer Treatments

TriSalus Life Sciences Advances Drug Delivery Technologies to Combat Liver and Pancreatic Tumors TriSalus Life Sciences Inc., an innovative medical technology company focused on oncology, is making si…

Cashu Finance·almost 2 years ago